Joia Mukherjee
Joia Mukherjee, MD, MPH
Chief Medical Officer, Partners In Health
Dr. Joia Mukherjee, MD, MPH is an internist, pediatrician, public health and infectious disease specialist, author, human rights advocate, and an associate professor at Harvard Medical School. Since 2000, Dr. Mukherjee has been chief medical officer of Partners In Health. Alongside PIH colleagues, Dr. Mukherjee provides preventive and curative health care as well as comprehensive social programs in Haiti, Rwanda, Lesotho, Malawi, Sierra Leone, Liberia, Peru, Mexico, Russia, Kazakhstan, and the Navajo Nation. Since the outbreak of the COVID-19 pandemic, she has lead the PIH team in supporting states and cities across the United States in their efforts to combat the virus. Because of her global health expertise—in HIV, tuberculosis, and Ebola, and most recently her global and US-based work in COVID-19 — she has been interviewed in print, broadcast, and other digital media.
In addition to her work with PIH, Dr. Mukherjee runs the master’s degree program in Global Health Delivery at Harvard Medical School, where she trains clinicians and scholars from across the globe to design, evaluate, and implement systems to deliver high-quality health care. She is the author of the widely used text book, An Introduction to Global Health Delivery: Practice, Equity, Human Rights (Oxford University Press), published in 2018. The second edition, with a focus on pandemics, will be released soon. Because of her expertise in infectious diseases, health systems, and social justice, she serves on the board of directors of Village Health Works (Burundi), Project Muso (Mali), Institute for Justice & Democracy (US and Haiti), and advises a number of grassroots medical organizations in their efforts to deliver health care with a human rights approach to poor communities across the globe. Dr. Mukherjee also consults for the World Health Organization and other international agencies on health system strengthening, human resources for health, treatment for HIV, hepatitis C, drug-resistant tuberculosis, and COVID-19.